The Bristol BioDesign Institute’s call for Innovation Placements will give ECRs the experience of working in growing synthetic biology companies.

Early career researchers (ECRs) are being offered the opportunity to gain experience of the innovative and dynamic environment of a rapidly growing synthetic biology spinout company, by taking part in an Innovation Placement.

The Bristol BioDesign Institute (BBI) has been awarded funding by BBSRC to support six Innovation Placements which will help ECRs to obtain industrially relevant skills by working in synthetic biology companies. These awards will cover salary costs for approximately 3 months, travel, subsistence, and other associated costs, up to a value of £20,000.

Photo galleries are not available for content from the previous KTN website: we apologise for this.

The six companies who have offered to host Innovation Placements are:

-  CytoSeek: Cell therapy spin-out company from the University of Bristol

-  Imophoron: Bristol-based synthetic biology start-up company

-  Rosa Biotech: Expected incorporation in early 2019, based in Bristol

-  Zentraxa: University of Bristol spin-out company

-  LabGenius: AI-driven synthetic biology start-up in London

-  OxSyBio: Synthetic biology company in Oxford

Applications must be submitted by Friday 15 February 2019. Further details on the placements on offer and how to apply can be found here.

Share this article